The previously observed supraclavicular depot of brown adipose tissue (BAT) in adult humans was commonly believed to be the equivalent of the interscapular thermogenic organ of small mammals. This view was recently disputed 1 on the basis of the demonstration that this depot consists of beige (also called brite) brown adipocytes, a newly identified type of brown adipocyte that is distinct from the classical brown adipocytes that make up the interscapular thermogenic organs of other mammals. A combination of high-resolution imaging techniques and histological and biochemical analyses showed evidence for an anatomically distinguishable interscapular BAT (iBAT) depot in human infants that consists of classical brown adipocytes, a cell type that has so far not been shown to exist in humans. On the basis of these findings, we conclude that infants, similarly to rodents, have the bona fide iBAT thermogenic organ consisting of classical brown adipocytes that is essential for the survival of small mammals in a cold environment.
On the basis of the seminal observation that human positron emission tomography scans sometimes show a symmetric cold-induced uptake of [ 18 F]-fluorodeoxyglucose 2 , three independent studies published in April 2009 demonstrated metabolically highly active BAT in adult humans [3] [4] [5] . Subsequent investigations showed an inverse association between obesity and type 2 diabetes mellitus and the presence of active BAT [6] [7] [8] . In rodents, it is evident not only that the distinct thermogenic BAT organ located in the interscapular region consists of brown adipocytes but also that a second type of brown adipocytes, so-called beige or brite cells, can appear in white adipose tissue (WAT) depots in response to cold or β3-adrenergic stimuli 9, 10 .
Recently, lineage tracing experiments revealed that the two types of brown adipocytes have different developmental origins 11 . Whereas classical brown adipocytes and skeletal muscle cells arise from precursors in the dermomyotome 12 , beige/brite cells seem to originate from endothelial and perivascular cells within WAT depots [13] [14] [15] . Recent data suggest that the previously described depots of human BAT are of the beige/brite type and raise the question of whether humans lack classical brown adipocytes altogether 1 ; this has also been the topic of a recent review 16 . Histomorphological studies performed in the 1960s and 1970s indicated the existence of brown adipocytes within the interscapular region in human infants and showed that these disappeared with age 17, 18 . Using a combination of high-resolution imaging techniques and morphological and biochemical analyses, we tested the hypothesis that human infants, similarly to small mammals, have an anatomically distinguishable iBAT depot consisting of classical brown adipocytes.
In an attempt to visualize potential iBAT in humans, we performed postmortem magnetic resonance imaging (MRI) of eight human infants. Using the fat fraction method 19 , we identified not only BAT depots in the supraclavicular region, as was recently demonstrated in a human infant using this technique 19 , but also a fat depot in the interscapular region presenting with an intermediate-fat fraction, in contrast to the high-fat fraction of the surrounding subcutaneous WAT (Supplementary Fig. 1 ). Using a three-dimensional reconstruction, we were able to compute the volume of the tissue depot with an average (± s.d.) volume of 3.6 ± 2.4 ml. The measured volume of the human infant iBAT depot in relation to the infant's total body volume is comparable in order of magnitude to the previously determined volume of the supraclavicular BAT depot in relation to total body volume in adults 5 . Figure 1 shows a representative reconstruction of the iBAT depot.
To confirm the existence of BAT in the imaged tissue in the interscapular region, we performed image-guided biopsies on four subjects and analyzed the samples using H&E staining and immunofluorescence for uncoupling protein 1 (UCP1), a protein that is unique to BAT. The sampled tissue consisted of packed multilocular brown adipocytes with very few interspersed unilocular UCP1-negative adipocytes and was delineated from the subcutaneous WAT by a layer of connective tissue (Fig. 2a) . Hence, the histomorphology of human iBAT closely resembles that of the typical iBAT depot found in rodents. Immunofluorescent staining for UCP1 and the mitochondrial marker cytochrome c oxidase revealed a high density of mitochondria with a near perfect colocalization of UCP1, thus confirming that the sampled tissue was BAT (Fig. 2b) .
To compare the appearance of the iBAT to that of other depots, we acquired BAT samples from two other locations (in adult humans) and studied their histological features. Similarly to the iBAT, samples from the periadrenal region of patients undergoing surgery for benign adrenal tumors and from the supraclavicular region of healthy volunteers showed mitochondria-rich and strongly UCP1-positive multilocular adipocytes (Fig. 2b) . However, in these two groups, the brown adipocytes were interspersed as clusters between unilocular UCP1-negative adipocytes (Fig. 2a,b) , resembling the clusters of beige/brite BAT located in WAT depots of cold-exposed rodents 10 .
On the basis of the available literature describing molecular markers of BAT, we identified Zic1 as the gene that best discriminates iBAT from beige/brite BAT in mice. Its expression is virtually absent in mouse beige/brite adipose tissue but is present in iBAT, as detected by quantitative real-time PCR 20 . We therefore performed immunofluorescence for ZIC1 in sections of human BAT. Whereas the iBAT showed distinct ZIC1 staining, the brown adipocytes of the supraclavicular and periadrenal BAT depots showed only faint expression of ZIC1 (Fig. 2c) . In line with the immunofluorescence results, we found that ZIC1 mRNA expression was highest in human BAT sampled from the interscapular region and was approximately 100-fold higher in iBAT than in supraclavicular BAT and 10-fold higher than in periadrenal BAT (Fig. 3a) . We also performed an image-guided biopsy in the perirenal region of one of the infant subjects. We grouped this sample with the adult periadrenal samples and found that the expression of ZIC1 in the infant tissue was within the range of expression in the adult periadrenal samples. For this specific infant, the expression of ZIC1 was approximately sixfold higher in iBAT compared to in BAT from the perirenal region (Fig. 3a) . This observation is important because it indicates that in infants, ZIC1 expression is higher in classical iBAT as compared with in other depots, a situation very similar to that in mice 20 .
To further characterize and compare the BAT samples from the different depots, we performed a more extensive gene expression analysis. Potential marker genes for classical and beige/brite BAT in mice have recently been described using clonal cell lines 1 . Among those, Eva1 (epithelial V-like antigen 1, also known as Mpzl2) was suggested to be a good marker for classical BAT, whereas Tbx1 and Tmem26 seemed to be reliable markers of mouse beige/brite BAT. In the human samples that we analyzed, the expression of EVA1 was significantly higher in periadrenal BAT as compared to in iBAT and supraclavicular BAT (Fig. 3b) . Hence, EVA1 seems to be an unsuitable marker for human iBAT. However, even in mice, the discriminatory potential of Eva1 expression is limited, as it differs only about fourfold between iBAT and beige/brite BAT 1 , whereas the expression of Zic1 is more than 1,000-fold higher in iBAT as compared to in beige/brite BAT 20 . In agreement with previous data 1 , the beige/brite marker TBX1 had significantly higher (tenfold) expression in supraclavicular BAT than in iBAT (Fig. 3c) , underscoring the different characteristics of these two BAT depots. We did not find any difference in TBX1 expression between iBAT and periadrenal BAT. This is in line with our own data from mice (data not shown), which indicate that Tbx1 may be a preferential marker npg for subcutaneous beige/brite depots rather than all beige/brite depots. We could detect no significant differences in TMEM26 expression between the three groups ( Fig. 3d) , suggesting that this marker for beige/brite cells, unlike in mice, is a poor marker for this cell type in humans. Thus, in humans, both ZIC1 and TBX1 seem to be markers that reliably discriminate between iBAT and BAT from other depots, which is in accordance with results derived from studies in mice 1, 20 . In mice, the homeobox genes Hoxc9 and Shox2 are differentially expressed in retroperitoneal beige/brite BAT as compared to in iBAT or other beige/brite or white depots. Hoxc9 expression is virtually absent in mouse iBAT and is twofold higher in the retroperitoneal than in the inguinal subcutaneous depot. Conversely, Shox2 expression is undetectable in mouse retroperitoneal beige/brite fat and iBAT but is readily detectable in the inguinal subcutaneous depot 20 . In the human samples that we examined, HOXC9 expression was approximately fivefold higher in the periadrenal BAT as compared to in the supraclavicular BAT and iBAT (Fig. 3e) , and SHOX2 expression in periadrenal BAT was approximately one-fifth that in supraclavicular BAT (Fig. 3f) . The finding that the retroperitoneally located periadrenal depot had high expression of HOXC9 and low expression of SHOX2 reflects the observations in mouse retroperitoneal compared to inguinal (subcutaneous) beige/brite adipose tissue 20 .
The expression of UCP1 (Fig. 3g) , the hallmark of BAT, was comparable between the three groups, as were the expressions of two other genes characteristic of BAT, DIO2 (deiodinase type II) and ADRB3 (β3-adrenergic receptor) (Fig. 3h,i) . Although a global Kruskal-Wallis test indicated significant differences in the expression of ADRB3 between the three groups, pairwise comparisons by Mann-Whitney U tests followed by Bonferroni-Holm corrections did not reach statistical significance. The genes encoding the two transcriptional co-regulators, PR domain containing 16 (encoded by PRDM16) and peroxisome proliferator-activated receptor γ coactivator 1α (encoded by PPARGC1A), both of which have crucial roles during the differentiation of brown adipocytes, were also expressed to a similar degree in all three BAT groups (Fig. 3j) .
Notably, our gene expression data might indicate the existence of several BAT depots differing in molecular characteristics rather than a dichotomy of classical and beige/brite BAT. However, the fact that the expression of UCP1, as well as that of other BAT-associated genes (DIO2, PRDM16 and PPARGC1A), was comparable in the human BAT depots we examined is important, as it suggests a functional equivalence of the tissues.
Ideally, different depots of human BAT should be compared within more homogenous groups of individuals; for example, within a cohort of human infants or adults rather than between the different groups. In reality, it is difficult to obtain biopsies of the kind used in this report. However, despite the differences in age, sex and genetic background between the cohorts from which we obtained the samples, our results are remarkably similar to the observed differences between classical iBAT and beige/brite BAT in inbred mice of the same age and on a constant genetic background 1, 20 . With this in mind and in support of the conclusions made here, we highlight the following: first, as in mice 20 , ZIC1 expression is significantly higher in human classical iBAT as compared with other depots, whereas TBX1 expression is significantly higher in supraclavicular BAT as compared with iBAT, Expression levels were normalized to ACTB. The red data points in a correspond to ZIC1 expression measured in interscapular and perirenal samples from the infant subject, from which both types of biopsies were taken. The global Kruskal-Wallis P values are shown above each graph. The P values for all pairwise comparisons, as indicated by the symbols, were done by Bonferroni-Holm-corrected MannWhitney U test. *P ≤ 0.05 for supraclavicular compared to interscapular, **P ≤ 0.01, ***P ≤ 0.001 for supraclavicular compared to periadrenal, # P ≤ 0.05 for interscapular compared to periadrenal; NS, not significant. npg in line with a previous study performed on mice 1 . Second, we demonstrate an anatomical localization of human classical iBAT identical to that in previously studied mammals such as mice and rats. Although previous studies have demonstrated an interscapular tissue with many of the characteristic features of BAT 18, 21 , by using advanced imaging and molecular analyses, we provide evidence for the presence of bona fide iBAT in human infants that consists of classical brown adipocytes as opposed to the beige/brite brown adipocytes found in other BAT depots. To our knowledge, we provide the first report of reliable MRIbased detection of iBAT in humans. The fact that different populations of brown adipocytes exist in humans is notable, as they might be differently affected by external stimuli and represent distinct potential targets for therapeutic intervention. Thus, reactivation of iBAT in adult humans may constitute an alternative approach to that of stimulation of beige/brite brown adipocytes when developing new therapies against obesity and obesity-linked diseases such as type 2 diabetes.
MeThOds
Methods and any associated references are available in the online version of the paper. 
ONLINe MeThOds
Subjects and biopsy procedures. Eight human infants, aged between 0 and 74 weeks, underwent MRI 24-48 h after death for the identification of BAT. The core body temperatures were approximately 5 °C during scanning. After image reconstruction, BAT-like tissue was identified on the basis of an intermediate-fat signal fraction between those of muscle and WAT, as has been discussed previously 19 . From four of the subjects (aged between 3 and 14 d), biopsies could be performed on the iBAT depot identified by MRI, and from one of the subjects, an MRI-guided biopsy could also be performed on the perirenal region. The biopsies were stored in RNAlater (Qiagen) at 4 °C until further processing. The MRI and biopsies were approved by the Regional Ethical Committee in Linköping (RMV M64-05 and 75-05).
The subjects and procedure for biopsy acquisition of supraclavicular BAT from healthy adults have been previously described 22 .
Periadrenal BAT samples from 15 patients undergoing surgery for benign adrenal tumors were evaluated for this study. The tumor and adjacent adipose tissue were removed using an endoscopic retroperitoneal approach according to standard procedures and immediately placed on ice. After sampling and assessment of the specimen by a pathologist, the remaining tumor and adjacent fat were partitioned and frozen in liquid nitrogen. The adipose tissue adjacent to the tumor was used for this study. The procedure was approved by the Institutional Review Board of LMU, Munich (project number 379-10), and all patients provided written informed consent.
MRI.
Postmortem MRI was performed using a 3.0T Ingenia clinical magnetic resonance scanner (Philips). A phased array head and neck coil was used for the acquisition of symmetrically sampled three-dimensional gradient dual echo 2-Point Dixon images 23 with echo times of approximately 3.30 ms (opposite-phase image) and 6.60 ms (in-phase image). The repetition time was 9.3 ms, and the flip angle was 10°. The resolution obtained was 0.75 mm 3 × 0.75 mm 3 × 0.75 mm 3 . Fat-and water-separated images were obtained using the inverse-gradient method 24 , and image inhomogeneity was corrected for by normalization of an interpolated bias field from identified pure adipose tissue voxels (for correction of the fat image) and pure muscle tissue voxels (for correction of the water image) 25, 26 .
Three-dimensional reconstruction of magnetic resonance images. The iBAT was segmented in the magnetic resonance images using a semiautomatic segmentation tool based on the Image Foresting Transform 27 . The identification of BAT was based on the normalized fat image (that is, the relative fat content in relation to a reference signal in subcutaneous tissue; Supplementary  Fig. 1 ). Object seed points were manually placed in regions where the relative fat content was in the range 0.1-0.7. Background seed points were placed in the surrounding tissue with relative fat content outside this range. The resulting segmentation was then rendered using the Multi Modality Workstation with InSpace three-dimensional software (Siemens Medical Solutions AG). The volumes of the segmented iBAT depots were calculated in Matlab software (MathWorks Inc) by calculating the number of voxels in each segmented region and multiplying by the voxel size.
Morphological and immunohistochemical studies. Frozen samples were cut in 10-µm sections on a CM3050 cryostat (Leica) and mounted on positively charged glass slides (Thermo Fisher Scientific). Sections were fixed in ice-cold acetone for 7 min and subsequently brought to water by an ethanol dilution series. H&E staining was performed according to standard procedures.
Immunofluorescence for UCP1 was carried out as follows: slides were incubated in blocking buffer consisting of DMEM (Life Technologies) supplemented with 10% FBS (Life Technologies) for 1 h at room temperature. A rabbit polyclonal antibody to UCP1 (Sigma, U6382) was used at a dilution of 1:500 in blocking buffer, and slides were incubated with the primary antibody at 4 °C overnight. Slides were subsequently washed with PBS and incubated with Alexa Fluor
